Toshiaki Hitomi

4.8k total citations
67 papers, 3.0k citations indexed

About

Toshiaki Hitomi is a scholar working on Health, Toxicology and Mutagenesis, Molecular Biology and Rheumatology. According to data from OpenAlex, Toshiaki Hitomi has authored 67 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Health, Toxicology and Mutagenesis, 18 papers in Molecular Biology and 16 papers in Rheumatology. Recurrent topics in Toshiaki Hitomi's work include Toxic Organic Pollutants Impact (18 papers), Moyamoya disease diagnosis and treatment (15 papers) and Effects and risks of endocrine disrupting chemicals (10 papers). Toshiaki Hitomi is often cited by papers focused on Toxic Organic Pollutants Impact (18 papers), Moyamoya disease diagnosis and treatment (15 papers) and Effects and risks of endocrine disrupting chemicals (10 papers). Toshiaki Hitomi collaborates with scholars based in Japan, China and South Korea. Toshiaki Hitomi's co-authors include Akio Koizumi, Kouji H. Harada, Hatasu Kobayashi, Wanyang Liu, Hiroko Okuda, Yukiko Fujii, Toshiyuki Habu, Shanika Nanayakkara, Toshiyuki Sakai and Takao Watanabe and has published in prestigious journals such as Environmental Science & Technology, PLoS ONE and Stroke.

In The Last Decade

Toshiaki Hitomi

67 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toshiaki Hitomi Japan 33 868 688 648 582 423 67 3.0k
Akio Koizumi Japan 38 1.6k 1.8× 743 1.1× 633 1.0× 663 1.1× 1.0k 2.4× 94 4.4k
Angeline S. Andrew United States 41 749 0.9× 89 0.1× 2.3k 3.5× 204 0.4× 658 1.6× 113 4.6k
Kayoko Inoue Japan 28 1.6k 1.9× 234 0.3× 223 0.3× 212 0.4× 1.6k 3.8× 49 2.5k
Neil Chernoff United States 36 1.1k 1.2× 125 0.2× 713 1.1× 52 0.1× 540 1.3× 103 3.1k
Éric Abadie France 30 97 0.1× 239 0.3× 631 1.0× 134 0.2× 754 1.8× 95 2.8k
Hye‐Youn Cho United States 34 700 0.8× 74 0.1× 2.7k 4.2× 65 0.1× 116 0.3× 82 4.9k
Donald A. Sens United States 30 1.6k 1.8× 122 0.2× 1.9k 3.0× 76 0.1× 91 0.2× 143 4.5k
Mary Ann Sens United States 30 1.8k 2.1× 80 0.1× 1.2k 1.8× 56 0.1× 119 0.3× 131 4.1k
Noriko Nishimura Japan 30 941 1.1× 51 0.1× 1.2k 1.8× 67 0.1× 92 0.2× 130 3.0k
Elisabeth Lie Norway 39 1.5k 1.7× 1.7k 2.5× 184 0.3× 46 0.1× 443 1.0× 91 4.0k

Countries citing papers authored by Toshiaki Hitomi

Since Specialization
Citations

This map shows the geographic impact of Toshiaki Hitomi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiaki Hitomi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiaki Hitomi more than expected).

Fields of papers citing papers by Toshiaki Hitomi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshiaki Hitomi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiaki Hitomi. The network helps show where Toshiaki Hitomi may publish in the future.

Co-authorship network of co-authors of Toshiaki Hitomi

This figure shows the co-authorship network connecting the top 25 collaborators of Toshiaki Hitomi. A scholar is included among the top collaborators of Toshiaki Hitomi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshiaki Hitomi. Toshiaki Hitomi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harada, Kouji H., et al.. (2024). Role of ABCB1 and ABCB4 in renal and biliary excretion of perfluorooctanoic acid in mice. Environmental Health and Preventive Medicine. 29(0). 21–21. 4 indexed citations
2.
Yoshida, Nao, Toshiaki Hitomi, Yukiko Fujii, et al.. (2024). Temporal trends in exposure to parabens, benzophenones, triclosan, and triclocarban in adult females in Kyoto, Japan, from 1993 to 2016. Environmental Science and Pollution Research. 31(25). 37050–37059. 1 indexed citations
3.
Takata, Ayako, et al.. (2024). Mesothelioma carcinogenesis of chrysotile and forsterite compared and validated by intraperitoneal injection in rat. Industrial Health. 63(1). 14–28. 4 indexed citations
4.
Harada, Kouji H., Tomoko Fujitani, Toshiaki Hitomi, et al.. (2023). Temporal trends in bisphenol exposures and associated health risk among Japanese women living in the Kyoto area from 1993 to 2016. Chemosphere. 316. 137867–137867. 17 indexed citations
5.
Mahmoud, Manal A. M., Usama T. Mahmoud, Meng Li, et al.. (2021). Systematic Review Protocol for the Current State of Chemical Exposure in Infants via Breast Milk, Artificial Milk and Dairy Products. International Journal of Environmental Research and Public Health. 18(9). 4436–4436. 2 indexed citations
6.
Harada, Kouji H., Yukiko Fujii, Jing Zhu, et al.. (2020). Analysis of Perfluorooctanesulfonate Isomers and Other Perfluorinated Alkyl Acids in Serum by In-Port Arylation Gas Chromatography Negative Chemical Ionization–Mass Spectrometry. Environmental Science & Technology Letters. 7(4). 259–265. 17 indexed citations
7.
Zhou, Sirui, Amirthagowri Ambalavanan, Daniel Rochefort, et al.. (2016). RNF213 Is Associated with Intracranial Aneurysms in the French-Canadian Population. The American Journal of Human Genetics. 99(5). 1072–1085. 41 indexed citations
8.
Nanayakkara, Shanika, Lalantha Senevirathna, Kouji H. Harada, et al.. (2015). Neonicotinoid concentrations in urine from chronic kidney disease patients in the North Central Region of Sri Lanka. Journal of Occupational Health. 58(1). 128–133. 36 indexed citations
9.
Kobayashi, Hatasu, Yoshiko Matsuda, Toshiaki Hitomi, et al.. (2015). Biochemical and Functional Characterization of RNF213 (Mysterin) R4810K, a Susceptibility Mutation of Moyamoya Disease, in Angiogenesis In Vitro and In Vivo. Journal of the American Heart Association. 4(7). 110 indexed citations
10.
Hitomi, Toshiaki, Toshiyuki Habu, Hatasu Kobayashi, et al.. (2013). Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G>A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients. Biochemical and Biophysical Research Communications. 438(1). 13–19. 94 indexed citations
11.
Liu, Wanyang, Lalantha Senevirathna, Toshiaki Hitomi, et al.. (2013). Genomewide association study identifies no major founder variant in Caucasian moyamoya disease. Journal of Genetics. 92(3). 605–609. 29 indexed citations
12.
Koizumi, Akio, Hatasu Kobayashi, Wanyang Liu, et al.. (2012). P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure. Environmental Health and Preventive Medicine. 18(2). 121–129. 56 indexed citations
13.
Senevirathna, Lalantha, Tilak Abeysekera, Shanika Nanayakkara, et al.. (2011). Risk factors associated with disease progression and mortality in chronic kidney disease of uncertain etiology: a cohort study in Medawachchiya, Sri Lanka. Environmental Health and Preventive Medicine. 17(3). 191–198. 49 indexed citations
14.
Kobayashi, Hatasu, Kōji Abe, Tohru Matsuura, et al.. (2011). Expansion of Intronic GGCCTG Hexanucleotide Repeat in NOP56 Causes SCA36, a Type of Spinocerebellar Ataxia Accompanied by Motor Neuron Involvement. The American Journal of Human Genetics. 89(1). 121–130. 181 indexed citations
15.
Niisoe, Tamon, Eitaro Nakamura, Kenji Harada, et al.. (2010). A global transport model of lead in the atmosphere. Atmospheric Environment. 44(14). 1806–1814. 25 indexed citations
16.
Harada, Kouji H., Hyeran Yang, Chan‐Seok Moon, et al.. (2010). Levels of perfluorooctane sulfonate and perfluorooctanoic acid in female serum samples from Japan in 2008, Korea in 1994–2008 and Vietnam in 2007–2008. Chemosphere. 79(3). 314–319. 95 indexed citations
17.
Matsuzaki, Y., Makoto Koyama, Toshiaki Hitomi, et al.. (2008). Arctiin induces cell growth inhibition through the down-regulation of cyclin D1 expression. Oncology Reports. 19(3). 721–7. 46 indexed citations
18.
Dai, Ping, Takuo Nakagami, Hideo Tanaka, Toshiaki Hitomi, & Tetsuro Takamatsu. (2007). Cx43 Mediates TGF-β Signaling through Competitive Smads Binding to Microtubules. Molecular Biology of the Cell. 18(6). 2264–2273. 88 indexed citations
19.
Matsuzaki, Y., et al.. (2004). Indole‐3‐carbinol activates the cyclin‐dependent kinase inhibitor p15INK4b gene. FEBS Letters. 576(1-2). 137–140. 24 indexed citations
20.
Matsuzaki, Y., et al.. (2002). Molecular cloning and characterization of the human p19INK4d gene promoter. FEBS Letters. 517(1-3). 272–276. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026